With just over 25 years’ experience in molecular automation development and manufacturing, BIT is excited to be exhibiting at AMP’s 25th-anniversary meeting.

Thanks to 25 years of leadership experience in hematology innovation, BIT has delivered more than 30,000 hematology instruments to its diagnostics clients.

BIT’s mission is to research, develop and manufacture innovative medical diagnostic devices for our partners to improve and save lives.

At the 2019 AACC Expo, BIT will proudly present their latest exciting cutting-edge instrumentation and technologies that are helping to revolutionize the IVD Industry.

Are you ready to transition your manual test to automation but can’t find a clear direction moving forward?
Let BIT help you solve your automation issues by leveraging 40 plus years of market experience and full solution offering.

BIT would like to formally introduce Nico Regente as their new Global Chief Financial Officer. Nico comes to BIT with 13 years of experience in finance and IT leadership roles at Castolin Eutectic, a company of the MEC Holding Group.

As the world’s premier Clinical Microbiology & Infectious Diseases event, ECCMID 2019 captures an audience of over 12,000 industry leaders and colleagues from all over the globe. BIT will exhibit our innovative IVD solutions. Come and meet us there.

MEDLAB 2019 looks to develop the value of laboratory medicine in shaping the future of healthcare. As the biggest home to the medical laboratory community in the MENA (Middle East and Northern Africa) region, MEDLAB provides a platform to connect industry leaders looking to partner together to achieve more with less resources.

How Augmented Reality and Virtual Reality are Creating Additional Value and Decreasing Costs in Medical Device Development, Manufacturing and Services.

Read BIT Group’s White Paper and watch our video on an exciting new development.

BIT will be presenting their featured AR/VR 3D Immersive Experience at the 2018 AMP Annual Meeting and Expo continuing to raise awareness of the benefits Immersive Reality adds to existing and future partner projects.

This year BIT launched and shared their AR/VR 3D Immersive Experience with attendees of the 2018 AACC Annual Meeting & Expo. Industry leaders from all over the world had the chance to visit BIT’s booth and learn through hands-on experience how Augmented and Virtual Reality simulations will help create major opportunities for the future of medical device development, manufacturing, and services.

It is BIT’s pleasure to announce that Luis de Luzuriaga will be taking on with immediate effect the role as Global CEO for BIT Group. Luis has been with BIT for three months serving as the CEO for BIT USA. Prior to joining BIT USA, he was the GM and Divisional VP of Abbott Hematology and has previously worked for Leica Biosystems, a Danaher company, Siemens and Bayer.

BIT and Qorvo® Biotechnologies invite esteemed guests of this year’s AACC Annual Expo to enjoy cocktails and hors d’oeuvres, mingle with global executive management and learn about the processes that drove these two companies to innovate the Life Sciences industry together.

BIT will exhibit at the AACC Annual Meeting & Expo in Chicago, IL (USA) July 31- August 2, 2018 and invites attendees and exhibitors to meet with members of BIT’s global team at their newly designed multi-level booth #3248.

BIT will be attending the 2nd edition of MedFIT, the first European business convention that is dedicated to innovation partnerships and early-stage investment in medtech and diagnostics.